Abstract
Groesser et al. demonstrate that pyogenic granuloma is a RAS pathway-driven tumor. This important observation adds yet another manifestation to the growing spectrum of cutaneous "RASopathies" and raises intriguing questions about the relationship between RAS pathway activation and malignancy.
Original language | English |
---|---|
Pages (from-to) | 359-360 |
Number of pages | 2 |
Journal | Journal of Investigative Dermatology |
Volume | 136 |
Issue number | 2 |
Early online date | 20 Jan 2016 |
DOIs |
|
Publication status | Published - Feb 2016 |